Articles From: Relypsa Announces Launch of Educational Website to Advance U.S. Physicians' Awareness and Understanding of Hyperkalemia to Epizyme Reports Publication of Preliminary Findings from Phase 1 Study of DOT1L Inhibitor EPZ-5676 in ASH Annual Meeting Abstract


JACKSONVILLE, Fla., Nov.
Sign-up for Stein Mart, Inc. Reports October and Third Quarter Sales investment picks
http://media.marketwire.com/attachments/201305/153545_PRLibertyLogo2c.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156723&ProfileId=051205&sourceType=1 VIRGINIA BEACH, VA --
Sign-up for Liberty Tax Service Offices to Open Early This Tax Season investment picks
2014/11/6
By Michael Calia Fannie Mae said its profit fell 55% as the firm reported lower revenue and a bigger tax provision than it did a year ago.
Sign-up for Fannie Mae profit falls 55% investment picks
2014/11/6
IIROC Trade Resumption - AEZ Canada NewsWire TORONTO , Nov.
Sign-up for IIROC Trade Resumption - AEZ investment picks
The GEO Group, Inc. (NYSE: GEO) ("GEO") announced that on November 5, 2014, its Board of Directors declared a quarterly cash dividend of $0.62 per share.
Sign-up for The GEO Group Declares Quarterly Cash Dividend of $0.62 Per Share investment picks
Fred's Inc. (NASDAQ: FRED) today reported sales for the four-week fiscal month of October, third quarter and nine-month year-to-date period ended November 1, 2014.
Sign-up for Fred's Reports October Sales investment picks
Data Group Ltd.
Sign-up for Data Group Ltd. announces third quarter results for 2014 investment picks
SAN DIEGO, Nov.
Sign-up for Royale Announces 3rd Quarter Profit investment picks
2014/11/6
ANN ARBOR, Mich.
Sign-up for Advanced Photonix to Webcast Fiscal 2015 Second Quarter Earnings investment picks
DirecTV (DTV) reported Thursday a third-quarter profit of $611 million, or $1.21 a share, down from $699 million, or $1.28 a share, in the year-earlier period.
Sign-up for DirecTV profit, sales beat estimates, but posts net decline in U.S. subscribers investment picks
2014/11/6
SAO PAULO , Nov.
Sign-up for BRASKEM announces 3Q14 Results investment picks
2014/11/6
PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) announces that consumers purchased more than 24,000 no!no! Hair removal units on a U.S. live home shopping television broadcast during a 24-hour event on November 3, which was the most units the no!no! hair removal device has ever sold on such a weekday live TV home shopping 24-hour event, generating retail sales of approximately $4.8 million.
Sign-up for no!no!™ Hair Breaks Record on Home Shopping Television with the Most Units Sold on a Weekday investment picks
- Revenue Increases to $75.3 million, up 13% from Q3'13 - Home Revenue Increases to $40.4 million, up 20% from Q3'13 - Company Raises Full-Year 2014 Revenue Guidance to be between $296 and $298 million - New Data Demonstrates Significant Improvement in Mortality, Hospitalization, and Patient Dropout with Home Hemodialysis when Compared with Peritoneal Dialysis LAWRENCE, Mass.
Sign-up for NxStage Reports Record Third Quarter 2014 Financial Results And Raises Full-Year Revenue Guidance investment picks
$5 MILLION to $8 MILLION IN AVOIDED UTILITY COSTS POWERING BETTER EDUCATION FOR STUDENTS BELMONT, Calif.
Sign-up for SunEdison And Irvine Unified School District Complete Latest 3 Solar Installations - 22 Schools Now Solar Powered investment picks
Stonegate Mortgage Corporation ("Stonegate Mortgage" or the "Company") (NYSE:SGM), a leading, non-bank mortgage company focused on originating, financing and servicing U.S. residential mortgage loans, today reported results for the quarter ended September 30, 2014.
Sign-up for Stonegate Mortgage Corporation Reports Third Quarter 2014 Financial Results investment picks
WARRINGTON, Pa.
Sign-up for Discovery Labs Reports Third Quarter 2014 Financial Results investment picks
Apollo Investment Corporation (NASDAQ:AINV) or the “Company,” or “Apollo Investment,” today announced financial results for its second fiscal quarter ended September 30, 2014.
Sign-up for Apollo Investment Corporation Reports Financial Results for the Quarter Ended September 30, 2014 investment picks
The Bon-Ton Stores, Inc. (NASDAQ:BONT) today announced that its financial results for the third quarter fiscal 2014 will be released on Thursday, November 20, 2014.
Sign-up for The Bon-Ton Stores, Inc. to Broadcast Review of Third Quarter Fiscal 2014 Results investment picks
DIRECTV (NASDAQ:DTV) today announced that third quarter 2014 revenues increased 6% to $8.37 billion, adjusted operating profit before depreciation and amortization 1 (OPBDA) and adjusted operating profit both increased 5% to $2.04 billion and $1.28 billion, respectively, and adjusted diluted earnings per share increased 4% to $1.33 compared to last year's third quarter.
Sign-up for DIRECTV Announces Third Quarter 2014 Results investment picks
2014/11/6
Product Revenue Increases 24% to $15.2 Million Product Gross Profit Increases 26% to $8.2 Million Conference Call and Webcast Today at 8:30 a.m. EST WALTHAM, Mass., Nov.
Sign-up for Repligen Reports Third Quarter 2014 Financial Results investment picks
2014/11/6
The company's brand dedicated to the design, manufacture and marketing of a broad range of buses and coaches makes its debut on the Brazilian market at FetransRio 2014, one of the country's largest trade fairs dedicated to the public transport sector.
Sign-up for Iveco Bus, the CNH Industrial brand dedicated to collective passenger transport, arrives in Brazil investment picks
Sunoco Logistics Partners L.P. (NYSE: SXL) today announced a successful open season for Sunoco Pipeline L.P.’s Mariner East 2 project, the second phase of the Company’s broader plan to provide critical pipeline transportation from the Marcellus and Utica Shales.
Sign-up for Sunoco Logistics to Invest Approximately $2.5 Billion for Mariner East 2 investment picks
Board of Directors Approves 2 for 1 Stock Split Reiterates Annual Guidance LAKE SUCCESS, N.Y. , Nov.
Sign-up for Hain Celestial Announces First Quarter Fiscal Year 2015 Record Net Sales and Adjusted Earnings Per Share investment picks
2014/11/6
NEW CASTLE, Pa.
Sign-up for Axion Power Letter to Shareholders investment picks
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced the publication on the website of the American Society of Hematology (ASH) of an abstract entitled “The DOT1L Inhibitor EPZ-5676: Safety and Activity in Relapsed/Refractory Patients with MLL-Rearranged Leukemia”. The abstract contains preliminary data from the Phase 1 trial of EPZ-5676, a potent and selective inhibitor of the DOT1L histone methyltransferase (HMT). EPZ-5676 is being developed for the treatment of acute leukemia with alterations in the MLL gene (MLL-r) or partial tandem duplications within MLL (MLL-PTD). The Company plans to present updated data from the trial at the 56 th annual meeting of ASH in San Francisco, Calif.
Sign-up for Epizyme Reports Publication of Preliminary Findings from Phase 1 Study of DOT1L Inhibitor EPZ-5676 in ASH Annual Meeting Abstract investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Relypsa Announces Launch of Educational Website to Advance U.S. Physicians' Awareness and Understanding of Hyperkalemia to Epizyme Reports Publication of Preliminary Findings from Phase 1 Study of DOT1L Inhibitor EPZ-5676 in ASH Annual Meeting Abstract
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent